#CCR5

A second man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.

“The Düsseldorf Patient” has been off HIV meds only since November 2018, so it is much too early to determine whether he has been cured.

Researchers think a more efficient means of modifying immune cells to resist the virus could yield a stronger effect.

Timothy Brown may have company after a man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.

Chinese scientist claims to have edited embryos to make children HIV resistant.

Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.

Researchers believe this genetic mutation protected against the 14th century-bubonic plague.

A pair of twin girls have been born as a part of his efforts, greatly alarming the worldwide research community.

A new study analyzes nuances in a cohort of six people who also received stem cell transplants for blood cancers.

Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.

In an ongoing trial of people on failing antiretroviral regimens, the injectable PRO 140 reduced viral load considerably.

Researchers will genetically engineer participants’ CD4 cells, disabling the attachment of the virus.

Researchers have used the cutting-edge CRISPR/Cas9 gene-editing technology to identify five potential targets for HIV treatments.

So why is he taking meds every day?

Investigators have created a consortium hoping to yield HIV cures through stem cell transplants like the ones that cured the Berlin Patient.

Cutting through the hype and hyperbole.